rehaneo, a nationwide leading provider of outpatient rehabilitation, aftercare, prevention and company health management founded in 2020, welcomes Fremman Capital to its shareholder group. Fremman is taking over the majority shares previously held by the European investment company Gimv. Founder and CEO Bruno Crone and co-founder and COO Christoph Dühr will remain significantly involved in the company and will continue to work in their existing roles.
Since it was founded four years ago – at the height of the corona pandemic – Gimv and the managing rehaneo partners Bruno Crone and Christoph Dühr have made the company one of the top 3 service providers in the area through a successful buy-and-build strategy of outpatient rehabilitation. Since 2023, Dr. Alain Robbe-Grillet as managing director and CFO of the group.
To date, rehaneo has integrated 13 companies nationwide into the group with a total of 23 locations, including some of the leading facilities in Germany. Most recently, rehaneo also founded and built a completely new center in Göttingen.
The rehaneo group now employs over 1,000 people who look after more than 80,000 patients and customers every year. Depending on the location, the centers’ offerings range from outpatient rehabilitation and rehabilitation aftercare to physical and occupational therapy through to prevention and fitness. In addition to the development of the locations and the continuous growth of the group, the focus is primarily on the quality of the services. This is guaranteed, among other things, by a Medical Board with well-known experts, including Prof. Dr. med. Thomas Wessinghage. The aim of rehaneo is to further consolidate the supply network and offer even more people professional rehabilitation measures close to their home.
On the one hand, the costs of outpatient rehabilitation are significantly lower than those of an inpatient stay, which benefits the health system. On the other hand, there is increasing demand from patients who want to remain in their usual environment during rehabilitation measures. Together with Fremman, the management team wants to continue the previous successful growth strategy and further consolidate the fragmented sector and thus build a leading company in Europe.
Bruno Crone, founder and CEO of the rehaneo groupexplained: We would like to thank Gimv for their active support and the trusting cooperation right from the start, without which it would not have been possible to become one of the leading quality providers in the field of outpatient rehabilitation in such a short time. We are pleased to be opening a new chapter in our success story with Fremman. Our focus will be on the acquisition of new outpatient rehabilitation centers and the strategic further development of the existing facilities and the entire group.“
Mirko Meyer-Schönherr and Max Schürenkrämer, founding partners and managing directors of Fremmanadd to: “ We are very impressed by the development of the rehaneo group to date and continue to see great potential in the outpatient rehabilitation market segment. We are pleased to support rehaneo’s experienced and ambitious management team in the further development of the group.“
Philipp von Hammerstein and Lars Timmer, partners and principal at Gimv Healthcare, explain: “ We are proud that, together with rehaneo, we have succeeded in building a leading company and competent partner in outpatient care in just four years, which is characterized by high customer and patient satisfaction as well as its high quality standards.“
The transaction is subject to approval by the Federal Cartel Office and is expected to be completed in Q1 2025. This transaction will have a positive impact of approximately EUR 1 per share on Gimv’s NAV as of September 30, 2024 (which will be published on November 21). The realized return from this transaction significantly exceeds the long-term portfolio return target.
About Gimv
Gimv is a European investment company with over 40 years of experience in private equity and is listed on Euronext Brussels and a member of the Euronext BEL ESG Index. Gimv currently has a portfolio of more than EUR 1.5 billion, consisting of around 60 portfolio companies with a total turnover of EUR 4.0 billion and more than 20,000 employees. Gimv identifies innovative, leading companies that have high growth potential and supports them sustainably on their path to market leadership. Each of the five investment platforms Consumer, Healthcare, Life Sciences, Smart Industries and Sustainable Cities is supported by a dedicated and competent team, based in Gimv’s domestic markets – Benelux, France and DACH – and by a comprehensive international network of experts is supported. www.gimv.com